Although Kaiso’s target genes in breast cancer are unknown, our findings suggest that Kaiso may function as an oncogene in IDC through inhibition of tumor suppressor gene expression whereas in ILC, Kaiso might harbor tumor suppressor functions by p120-mediated relieve of transcriptional repression of oncogenic target genes. This evidence concerns the gene CTNND1 and breast carcinoma.